MXPA04001001A - PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION. - Google Patents

PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION.

Info

Publication number
MXPA04001001A
MXPA04001001A MXPA04001001A MXPA04001001A MXPA04001001A MX PA04001001 A MXPA04001001 A MX PA04001001A MX PA04001001 A MXPA04001001 A MX PA04001001A MX PA04001001 A MXPA04001001 A MX PA04001001A MX PA04001001 A MXPA04001001 A MX PA04001001A
Authority
MX
Mexico
Prior art keywords
adhd
treatment
pramipexole
propylamino
benzothiazole
Prior art date
Application number
MXPA04001001A
Other languages
English (en)
Spanish (es)
Inventor
Reess Juergen
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04001001A publication Critical patent/MXPA04001001A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04001001A 2001-08-03 2002-07-31 PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION. MXPA04001001A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10137633A DE10137633A1 (de) 2001-08-03 2001-08-03 Pramipexol zur Behandlung von ADHD
PCT/EP2002/008500 WO2003013520A1 (de) 2001-08-03 2002-07-31 Pramipexol zur behandlung von adhd

Publications (1)

Publication Number Publication Date
MXPA04001001A true MXPA04001001A (es) 2004-04-20

Family

ID=7693957

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001001A MXPA04001001A (es) 2001-08-03 2002-07-31 PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION.

Country Status (8)

Country Link
EP (1) EP1416930A1 (https=)
JP (1) JP2005500368A (https=)
AR (1) AR035273A1 (https=)
CA (1) CA2453485A1 (https=)
DE (1) DE10137633A1 (https=)
MX (1) MXPA04001001A (https=)
UY (1) UY27408A1 (https=)
WO (1) WO2003013520A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200906997A1 (tr) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621133A (en) * 1989-05-31 1997-04-15 Deninno; Michael P. Dopamine agonists
US7049337B2 (en) * 2000-05-19 2006-05-23 Wayne State University Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential CNS receptor activity and behavior
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system

Also Published As

Publication number Publication date
AR035273A1 (es) 2004-05-05
DE10137633A1 (de) 2003-02-20
EP1416930A1 (de) 2004-05-12
CA2453485A1 (en) 2003-02-20
JP2005500368A (ja) 2005-01-06
WO2003013520A1 (de) 2003-02-20
UY27408A1 (es) 2003-02-28

Similar Documents

Publication Publication Date Title
GB0111523D0 (en) Chemical compounds
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
DE60112974D1 (en) Carbolinderivate
GB0225475D0 (en) Therapeutic agents
ATE449081T1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
MXPA05002442A (es) Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SE9904176D0 (sv) New use
HUP0000487A2 (hu) Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok
UA81624C2 (ru) Тризамещённые гетероарилы и способ их получения и применение
CO5271691A1 (es) Nuevos compuestos
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
DE60216233D1 (en) Carbolinderivate
PL1855677T3 (pl) 3,11B-Cis-dihydrotetrabenazyny do leczenia schizofrenii i innych psychoz
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
MXPA03010761A (es) Combinaciones farmaceuticas.
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
MY138826A (en) 2,7-substituted indoles
AU2003303141A1 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
MXPA04000775A (es) Uso novedoso del 2 -[5-(4-fluorofenil) -3-piridilmetilamino-metil] -cromano y sus sales fisiologicamente aceptables.
MXPA04001001A (es) PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal